http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9555760&dopt=Abstract
-
Comment in:
Incidence of adverse drug reactions in hospitalized
patients: a meta-analysis of prospective studies.
Lazarou J, Pomeranz BH, Corey PN.
Department of Zoology, University of Toronto, Ontario, Canada.
OBJECTIVE: To estimate the incidence of serious and fatal adverse drug
reactions (ADR) in hospital patients. DATA SOURCES: Four electronic databases
were searched from 1966 to 1996. STUDY SELECTION: Of 153, we selected 39
prospective studies from US hospitals. DATA EXTRACTION: Data extracted
independently by 2 investigators were analyzed by a random-effects model. To
obtain the overall incidence of ADRs in hospitalized patients, we combined the
incidence of ADRs occurring while in the hospital plus the incidence of ADRs
causing admission to hospital. We excluded errors in drug administration,
noncompliance, overdose, drug abuse, therapeutic failures, and possible ADRs.
Serious ADRs were defined as those that required hospitalization, were
permanently disabling, or resulted in death. DATA SYNTHESIS: The overall
incidence of serious ADRs was 6.7% (95% confidence interval [CI], 5.2%-8.2%)
and of fatal ADRs was 0.32% (95% CI, 0.23%-0.41%) of hospitalized patients. We
estimated that in 1994 overall 2216000 (1721000-2711000) hospitalized patients
had serious ADRs and 106000 (76000-137000) had fatal ADRs, making these
reactions between the fourth and sixth leading cause of death. CONCLUSIONS:
The incidence of serious and fatal ADRs in US hospitals was found to be
extremely high. While our results must be viewed with circumspection because
of heterogeneity among studies and small biases in the samples, these data
nevertheless suggest that ADRs represent an important clinical issue.
Publication Types:
PMID: 9555760 [PubMed - indexed for MEDLINE]